Stakeholders disagree over FDA’s regulatory approach to generative AI
Regulatory NewsFerdous Al-Faruque
Advisory committeesArtificial intelligence/machine learning (AI/ML)Diagnostics/IVDsDigital health/SaMD/AIMedical DevicesRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)